Comments on “Immune Checkpoint Inhibitor‐Based Adjuvant Treatment Versus Surveillance in Curatively Treated Hepatocellular Carcinoma: A Systematic Review and meta‐Analysis”

Key Points

• This commentary addresses the findings and implications of adjuvant treatment versus surveillance for hepatocellular carcinoma.
• Systematic review of existing literature on immune checkpoint inhibitors and surveillance practices.
• Analysis of treatment outcomes and patient management strategies in hepatocellular carcinoma cases.
• No datasets were generated or analyzed, focusing primarily on existing findings and interpretations.